298 related articles for article (PubMed ID: 12198876)
1. [Esophageal carcinoma in an advanced stage. The value of surgery plus radiochemotherapy].
Theisen J; Siewert JR
MMW Fortschr Med; 2002 Jul; 144(27-28):36-8. PubMed ID: 12198876
[No Abstract] [Full Text] [Related]
2. [Preoperative radiochemotherapy of esophageal carcinoma. Light at the end of the tunnel?].
Hölscher AH; Metzger R; Schneider PM
Zentralbl Chir; 2000; 125(4):319-25. PubMed ID: 10829311
[TBL] [Abstract][Full Text] [Related]
3. Has combined modality therapy improved the outlook in carcinoma of the esophagus?
Philip PA; Ajani JA
Oncology (Williston Park); 1994 Sep; 8(9):37-42; discussion 44-5, 50-2, 61. PubMed ID: 7527642
[TBL] [Abstract][Full Text] [Related]
4. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer.
Vallböhmer D; Hölscher AH; DeMeester S; DeMeester T; Salo J; Peters J; Lerut T; Swisher SG; Schröder W; Bollschweiler E; Hofstetter W
Ann Surg; 2010 Nov; 252(5):744-9. PubMed ID: 21037429
[TBL] [Abstract][Full Text] [Related]
5. [Interdisciplinary multi-modality therapy of advanced hypopharyngeal and proximal esophageal carcinomas].
Fass J; Dreuw B; Korves B; von Saldern S; Andreopoulos B; Schumpelick V
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1502-4. PubMed ID: 9931925
[TBL] [Abstract][Full Text] [Related]
6. [Current diagnosis and therapy of esophageal carcinoma].
Mühr-Wilkenshoff F; Stahl M; Faiss S; Zeitz M; Scherübl H
Z Gastroenterol; 2004 Jul; 42(7):615-21. PubMed ID: 15248111
[TBL] [Abstract][Full Text] [Related]
7. Esophageal carcinoma: impact of staging on treatment.
Siewert JR; Dittler HJ
Endoscopy; 1993 Jan; 25(1):28-32. PubMed ID: 8453923
[No Abstract] [Full Text] [Related]
8. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
Elsaleh H; Farrell JJ; Crane CH
J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
[No Abstract] [Full Text] [Related]
9. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.
Incarbone R; Bonavina L
Cancer; 1999 Nov; 86(9):1883-5. PubMed ID: 10547564
[No Abstract] [Full Text] [Related]
10. Section II: pathology and pathologic staging of esophageal cancer.
Glickman JN
Semin Thorac Cardiovasc Surg; 2003 Apr; 15(2):167-79. PubMed ID: 12838487
[TBL] [Abstract][Full Text] [Related]
11. Outcome of esophageal carcinoma in the veteran affairs population: a comparative analysis from the Veteran Affairs Central Cancer Registry.
Beg MS; Navaneethan U; Atiq M; Komrokji R; Safa M
Am J Clin Oncol; 2009 Jun; 32(3):286-90. PubMed ID: 19433959
[TBL] [Abstract][Full Text] [Related]
12. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
Chang DT; Chapman C; Shen J; Su Z; Koong AC
Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
[TBL] [Abstract][Full Text] [Related]
13. Advances in the medical management of advanced gastrointestinal cancers.
Tempero MA
Curr Opin Oncol; 1990 Aug; 2(4):747-53. PubMed ID: 2095882
[No Abstract] [Full Text] [Related]
14. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.
Xi H; Baldus SE; Warnecke-Eberz U; Brabender J; Neiss S; Metzger R; Ling FC; Dienes HP; Bollschweiler E; Moenig S; Mueller RP; Hoelscher AH; Schneider PM
Clin Cancer Res; 2005 Dec; 11(23):8341-7. PubMed ID: 16322294
[TBL] [Abstract][Full Text] [Related]
15. [Esophageal carcinoma -- current status in diagnosis and therapy].
Baumhoer D; Ramadori G
Z Gastroenterol; 2005 Apr; 43(4):399-409. PubMed ID: 15830307
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological profile of carcinoma of oesophagus at Aligarh.
Ansari MM; Beg MH; Haleem S
J Indian Med Assoc; 1991 Aug; 89(8):217-9. PubMed ID: 1721079
[TBL] [Abstract][Full Text] [Related]
17. Palliation of carcinoma of the esophagus: is there a hope for cure?
Lambert R
Am J Gastroenterol; 1994 Aug; 89(8 Suppl):S27-40. PubMed ID: 7519392
[No Abstract] [Full Text] [Related]
18. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer].
Fuchs HF; Hölscher AH
Zentralbl Chir; 2014 Feb; 139(1):32-6. PubMed ID: 24585195
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of early esophageal cancer: differences between squamous cell carcinoma and adenocarcinoma.
Bollschweiler E; Hölscher AH
Ann Surg; 2007 Feb; 245(2):334. PubMed ID: 17245190
[No Abstract] [Full Text] [Related]
[Next] [New Search]
